Case Western Reserve University gets $2.9M grant to create chairside oral cancer test
By Ariana Portalatin
Originally at beckersdental.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
A new chairside oral-cancer test in development could let general dentists and specialists triage suspicious lesions immediately, potentially reducing unnecessary biopsies and specialist referrals while protecting revenue from missed malignancies.
Key points
- Five-year, $2.93 million NIH-level grant awarded to CWRU School of Dental Medicine for the BDI fluorescence immunoassay.
- Test uses a simple swab or rinse to measure the ratio of two naturally occurring peptides; abnormal ratios flag lesions needing biopsy.
- If validated, the point-of-care device could be deployed in any dental office, changing screening protocols and malpractice risk for oral-pathology cases.
- Timeline: results expected within five years; no immediate practice change but practices should monitor for FDA clearance and CPT coding updates.
Who should care
Read the original on Becker's Dental + DSO Review
Full reporting and any paywall content live on beckersdental.com. We summarize and score; we do not republish.
Related
- ·Business
Why the dental assistant shortage could get worse
- ·Business
US Oral Surgery Management exec on M&A: ‘We’ve had to be even more disciplined’
- ·Research
Vertical dimension of occlusion restoration using a digital injectable composite resin technique: A 5-year clinical follow-up
- ·Research
A digitally guided workflow integrating tooth preparation and restoration positioning for minimally invasive veneer and partial-coverage restorations: A dental technique